TY - JOUR
T1 - Late-onset inversa recessive dystrophic epidermolysis bullosa caused by glycine substitutions in collagen type VII
AU - Leverkus, M.
AU - Ambach, A.
AU - Hoefeld-Fegeler, M.
AU - Kohlhase, J.
AU - Schmidt, E.
AU - Schumann, H.
AU - Has, C.
AU - Gollnick, H.
PY - 2011/5/1
Y1 - 2011/5/1
N2 - Dystrophic epidermolysis bullosa (DEB) is a rare hereditary skin disorder caused by mutations in COL7A1, encoding collagen type VII.1 Clinical manifestations of COL7A1 mutations range from generalized skin blistering to mild localized blistering or nail dystrophy.2 The investigation of the molecular basis of DEB has revealed more than 540 different mutations that cannot entirely explain phenotypic variations (HGMD® Professional 2010.3, https://portal.biobase-international. com/hgmd/). Inversa recessive DEB (RDEB-I) is a subtype characterized by generalized blistering in the neonatal period. The condition improves with age, and in adults blistering is restricted to intertriginous areas, and severe lesions of the oral and genital mucosa and nail changes occur in the majority of described patients.2 Recent data suggested that amino-acid substitutions affecting arginines or glycines at borders of collagenic subdomains might cause this phenotype.3 We report a German patient with an unusually mild RDEB-I harbouring compound heterozygous mutations in COL7A1.
AB - Dystrophic epidermolysis bullosa (DEB) is a rare hereditary skin disorder caused by mutations in COL7A1, encoding collagen type VII.1 Clinical manifestations of COL7A1 mutations range from generalized skin blistering to mild localized blistering or nail dystrophy.2 The investigation of the molecular basis of DEB has revealed more than 540 different mutations that cannot entirely explain phenotypic variations (HGMD® Professional 2010.3, https://portal.biobase-international. com/hgmd/). Inversa recessive DEB (RDEB-I) is a subtype characterized by generalized blistering in the neonatal period. The condition improves with age, and in adults blistering is restricted to intertriginous areas, and severe lesions of the oral and genital mucosa and nail changes occur in the majority of described patients.2 Recent data suggested that amino-acid substitutions affecting arginines or glycines at borders of collagenic subdomains might cause this phenotype.3 We report a German patient with an unusually mild RDEB-I harbouring compound heterozygous mutations in COL7A1.
UR - http://www.scopus.com/inward/record.url?scp=79955396449&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2133.2011.10230.x
DO - 10.1111/j.1365-2133.2011.10230.x
M3 - Journal articles
C2 - 21275939
AN - SCOPUS:79955396449
SN - 0007-0963
VL - 164
SP - 1104
EP - 1106
JO - British Journal of Dermatology
JF - British Journal of Dermatology
IS - 5
ER -